Chemotherapy for trophoblastic disease: Current standards

Expert Review of Anticancer Therapy

Volumn 3, Issue 1, 2003, Pages 48-54

  Kendall, Anne ^a   Gillmore, Roopinder ^b   Newlands, Edward ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Human chorionic gonadotrophin; Placental site trophoblastic tumors; Trophoblastic disease

Indexed keywords

ANTINEOPLASTIC AGENT; BENZIMIDAZOLE; CARBOPLATIN; CHLORAMBUCIL; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FOLINATE CALCIUM; FOLINIC ACID; GEFITINIB; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IFOSFAMIDE; IRINOTECAN; MELPHALAN; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PEMETREXED; SEMAXANIB; TEMOZOLOMIDE; THALIDOMIDE; UNINDEXED DRUG; VATALANIB; VINCRISTINE;

ADULT; ALOPECIA; BENIGN TUMOR; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BREAST CANCER; CHORIOCARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; CURETTAGE; DERMATITIS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HYDATIDIFORM MOLE; INCIDENCE; METASTASIS; MUCOSA INFLAMMATION; MYELOID LEUKEMIA; NEPHROTOXICITY; PLACENTA DISORDER; PREGNANCY COMPLICATION; PROGNOSIS; REGULATORY MECHANISM; REVIEW; SCORING SYSTEM; SCREENING TEST; STOMATITIS; TREATMENT INDICATION; TREATMENT PLANNING; TROPHOBLAST; TROPHOBLASTIC DISEASE;

EID: 0037321190     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.3.1.48     Document Type: Review

References (14)

1. Tidy JA, Gillespie AM, Bright N, Radstone CR, Coleman RE, Hancock BW. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol. Oncol. 78(3 Pt 1), 309-312 (2000).
2. Seckl MJ, Newlands ES. Treatment of gestational trophoblastic disease. Genet. Diagn. Pathol. 143(2-3), 159-171 (1997).
3. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am. J. Obstet. Gynecol. 115(4), 451-457 (1973).
4. Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 38(3), 1373-1385 (1976).
5. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int. J. Gynecol. Cancer 11(1), 73-77 (2001).
6. Hancock BW, Welch EM, Gillespie AM, Newlands ES. A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int. J. Gynecol. Cancer 10(4), 318-322 (2000).
7. Matsui H, Iitsuka Y, Seki K, Sekiya S. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Gynecol. Obstet. Invest. 46(1), 5-8 (1998).
8. Dobson LS, Lorigan PC, Coleman RE, Hancock BW. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br. J. Cancer 82(9), 1547-1552 (2000).
9. McNeish IA, Strickland L, Holden et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J. Clin. Oncol. 20(7), 1838-1844 (2002)
10. Bower M, Newlands ES, Holden L et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J. Clin. Oncol. 15(7), 2636-2643 (1997).
11. Matsui H, Suzuka K, Iitsuka Y, Seki K, Sekiya S. Combination chemotherapy with methotrexate, etoposide and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol. Oncol. 78(1), 28-31 (2000).
12. Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J. Clin. Oncol. 18(4), 854-859 (2000).
13. Rustin GJ, Newlands ES, Lutz JM et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J. Clin. Oncol. 14(10), 2769-2773 (1996).
14. Schorge JO, Goldstein DP, Bernstein MR, Berkowitz RS. Recent advances in gestational trophoblastic disease. J. Reprod. Med. 45(9), 692-700 (2000).